Last updated: 19 April 2023 at 4:40pm EST

John Nicols Net Worth




The estimated Net Worth of John J Nicols is at least $16.4 Million dollars as of 17 April 2023. Mr. Nicols owns over 71,428 units of Codexis stock worth over $2,237,724 and over the last 21 years he sold CDXS stock worth over $10,728,678. In addition, he makes $3,408,030 as President, Chief Executive Officer und Director at Codexis.

Mr. Nicols CDXS stock SEC Form 4 insiders trading

John has made over 38 trades of the Codexis stock since 2004, according to the Form 4 filled with the SEC. Most recently he exercised 71,428 units of CDXS stock worth $140,713 on 17 April 2023.

The largest trade he's ever made was selling 95,443 units of Codexis stock on 20 April 2012 worth over $6,082,582. On average, John trades about 23,676 units every 98 days since 2004. As of 17 April 2023 he still owns at least 819,679 units of Codexis stock.

You can see the complete history of Mr. Nicols stock trades at the bottom of the page.





John Nicols biography

John J. Nicols serves as President, Chief Executive Officer, Director of Codexis, Inc. Mr. Nicols brings to our board of directors his knowledge of Codexis as its President and Chief Executive Officer and his extensive prior management experience in the chemicals industry. Prior to that time, Mr. Nicols served in various capacities at Albemarle Corporation, a public company focused on the development, manufacture and marketing of highly engineered specialty chemicals, since he joined that company in 1990. Mr. Nicols most recently served as its Senior Vice President, Strategic Development and Catalysts, from March 2012 to June 2012. Mr. Nicols previously served as its Vice President, Catalysts from January 2007 to February 2012, its Vice President, Fine Chemistry from June 2002 to December 2006, its Division Vice President, Global Flame Retardants business from February 1999 through June 2002 and its Asia Pacific Business Director for the Bromine Chemicals business, based in Tokyo, Japan, from 1995 to 1998. Prior to his time with Albemarle Corporation, Mr. Nicols worked for three years in manufacturing and research and development for Hercules, Inc. Mr. Nicols has served on the board of directors of California Life Sciences Association (formerly BayBio), a non-profit organization, since January 2014. In addition, Mr. Nicols has served on the board of directors of Solve ME/CFS Initiative, a non-profit organization, since January 2015, and currently serves as chairperson and on the executive and nominating committees of that organization. Mr. Nicols received a B.S. in Chemical Engineering from the Polytechnic Institute of New York University and an M.B.A. from the Sloan School of Management at the Massachusetts Institute of Technology.

What is the salary of John Nicols?

As the President, Chief Executive Officer und Director of Codexis, the total compensation of John Nicols at Codexis is $3,408,030. There are no executives at Codexis getting paid more.



How old is John Nicols?

John Nicols is 56, he's been the President, Chief Executive Officer und Director of Codexis since 2012. There are 10 older and 1 younger executives at Codexis. The oldest executive at Codexis Inc. is Thomas Baruch, 81, who is the Independent Director.

What's John Nicols's mailing address?

John's mailing address filed with the SEC is C/O CODEXIS, INC., 200 PENOBSCOT DRIVE, REDWOOD CITY, CA, 94063.

Insiders trading at Codexis

Over the last 15 years, insiders at Codexis have traded over $34,923,852 worth of Codexis stock and bought 399,963 units worth $1,488,111 . The most active insiders traders include Ventures Vii, Llc Vivo Vent..., Ventures Life Sciences 2000... und John J Nicols. On average, Codexis executives and independent directors trade stock every 32 days with the average trade being worth of $153,997. The most recent stock trade was executed by Byron L Dorgan on 15 November 2023, trading 20,000 units of CDXS stock currently worth $42,200.



What does Codexis do?

codexis, inc. is a leading protein engineering company applying innovative technologies to unlock the power of proteins™. our proprietary codeevolver® technology platform enables the rapid development and production of highly optimized proteins, custom-designed for your application. codexis’ revolutionary approach to protein engineering starts with an understanding of the desired performance specifications and optimizes a protein specifically to fit these requirements. you get precisely the protein you need for the job you want it to do. guided by proprietary artificial intelligence software and advanced high-throughput screening systems, codexis is able to efficiently generate and introduce function-driven mutations to rapidly improve a protein for its target application. since 2002, codexis’ in-house biochemists, biologists and bioinformatics experts have worked closely with our clients to advance the technologies for protein optimization and production, enabling breakthrough develop



Complete history of Mr. Nicols stock trades at Codexis und Albemarle

Insider
Trans.
Transaktion
Gesamtpreis
John J Nicols
Optionausübung $140,713
17 Apr 2023
John J Nicols
Optionausübung $140,713
15 Mar 2023
John J Nicols
Verkauf $385,800
23 Feb 2023
John J Nicols
Verkauf $490,744
23 Jan 2023
John J Nicols
Verkauf $428,079
9 Dec 2022
John J Nicols
Verkauf $497,545
15 Nov 2022
John J Nicols
Verkauf $423,566
27 Oct 2022
John J Nicols
Verkauf $454,528
5 Oct 2022
John J Nicols
Optionausübung $179,800
12 Aug 2022
John J Nicols
Optionausübung $178,640
11 May 2022
John J Nicols
Optionausübung $178,640
9 Mar 2022
John J Nicols
Optionausübung $210,210
10 Nov 2021
John J Nicols
Optionausübung $242,200
12 Aug 2021
John J Nicols
Optionausübung $243,532
17 May 2021
John J Nicols
Kauf $133,000
20 Aug 2019
John J Nicols
Kauf $133,000
20 Aug 2019
John J Nicols
Optionausübung $190,549
18 Mar 2019
John J Nicols
Optionausübung $151,590
6 Dec 2018
John J Nicols
Optionausübung $276,800
27 Sep 2018
John J Nicols
Optionausübung $49,336
14 Aug 2018
John J Nicols
Optionausübung $31,164
8 Jun 2018
John J Nicols
Optionausübung $77,729
22 Mar 2018
John J Nicols
Kauf $65,340
8 Mar 2013
John J Nicols
Kauf $119,880
6 Mar 2013
John J Nicols
VP Fine Chemicals
Verkauf $6,082,582
20 Apr 2012
John J Nicols
VP Fine Chemicals
Optionausübung $383,520
1 Apr 2012
John J Nicols
VP Fine Chemicals
Optionausübung $555,576
24 Feb 2012
John J Nicols
VP Fine Chemicals
Kauf $123,585
8 Aug 2011
John J Nicols
VP Fine Chemicals
Verkauf $727,458
29 Apr 2010
John J Nicols
VP Fine Chemicals
Optionausübung $501,750
1 Jan 2009
John J Nicols
VP Fine Chemicals
Optionausübung $834,750
5 Feb 2008
John J Nicols
VP Fine Chemicals
Verkauf $1,238,375
29 Oct 2007
John J Nicols
VP Fine Chemicals
Optionausübung $154,980
20 Feb 2007
John J Nicols
VP Fine Chemicals
Optionausübung $269,925
3 Jan 2007
John J Nicols
VP Fine Chemicals
Optionausübung $309,960
12 Jun 2006
John J Nicols
VP Fine Chemicals
Optionausübung $161,400
16 Feb 2006
John J Nicols
VP Fine Chemicals
Optionausübung $265,608
3 Nov 2005
John J Nicols
VP Fine Chemicals
Optionausübung $526,950
9 Nov 2004


Codexis executives and stock owners

Codexis executives and other stock owners filed with the SEC include: